PR in the Philippines

TransNusa Increases Flight Options For Two Routes From ManadoPT TransNusa Aviation Mandiri converts two chartered flights from Manado to scheduled commercial flightsTickets sale for Manado to Shanghai and Manado to Shenzhen started on July 29, 2025TransNusa continuously expands international route and starts strengthening Manado base in IndonesiaJAKARTA, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - FOCUSING on organic growth, TransNusa converts two charter flight routes between Manado and Shanghai as well as Manado and Shenzhen to scheduled commercial routes, starting 8 September and 2 October, respectively.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said while the Manado-Shenzhen scheduled commercial flight is direct, the Manado-Shanghai flight plan has a stop-over of between 30 to 35 minutes at the Clark International Airport.“Our main priority and focus is to create new exciting routes for our passengers and offer seamless and fast travels, whether through direct routes or transits routes.” Datuk Francis said, explaining that the Manado-Clark-Shenzhen route is very popular among tourists.“With the launch of these new commercial routes, we hope to provide tourists from Manado and China additional options to travel,” Datuk Francis said, adding that TransNusa will also provide its passengers with options to visit other major tourist destinations from Manado, such as Bali, also known as Indonesia’s Island of Gods.Details of the new RoutesFrom October 2, TransNusa will be operating three flights a week from Manado’s Sam Ratulangi International Airport to Shenzhen Bao’an International Airport. The TransNusa flight, 8B 175, will depart Manado at 21.10pm and arrive at the Shenzhen Bao’an International Airport at 01.00am while TransNusa flight, 8B 176, will depart Shenzhen Bao’an International Airport at 02.00am and arrive in Manado at 05.50am.TransNusa will be operating the Manado-Shenzhen route three times weekly. The Manado-Shenzhen route scheduled commercial flights are on Tuesday, Thursday and Saturday while the Shenzhen-Manado route scheduled commercial flights will be on Wednesday, Friday and Sunday.TransNusa’s scheduled Manado-Shenzhen flight ticket price starts from as low as IDR3.499.000, CNY1.525 and USD226 while it’s schedule flight from Manado to Shanghai ticket price starts from as low as IDR3.988.000, CNY1.688 and USD257. TransNusa tickets are available for purchase at transnusa.co.id and all other main online travel agent platforms worldwide.Meanwhile, the TransNusa flight, 8B 101, from Manado will depart at 14.00pm and arrive at the Clark International Airport at 16.40pm. The flight will depart Clark International Airport at 17.15pm and arrive at the Shanghai Pudong International Airport at 20.55pm. The flight, 8B 102, will depart the Shanghai Pudong International Airport at 23.05pm and arrive at Clark International Airport at 02.30am. The TransNusa 8B 102, will depart Clark International Airport at 03.00am and arrive at Manado’s Sam Ratulangi International Airport at 05.30am.Datuk Bernard said that TransNusa will operate the six hours 50 minutes scheduled commercial flight route 3 times week. TransNusa’s scheduled commercial flight from Manado will depart on Monday, Wednesday, and Friday.For both the newly introduced scheduled commercial flights, Datuk Bernard said TransNusa will be utilizing its C909 jet airliner, which has only 95 seats, to ensure that passengers travel with comfort.Datuk Bernard Francis…TransNusa offers new flight options for its passengersBrief History On TransNusaTransNusa, which had to close business due to the Covid-19 pandemic was injected with new shareholders and management team in 2022. The airline opened its doors for business in October and within six months, in April 2023, launched its first international flight from Jakarta to Kuala Lumpur, Malaysia.After which, under the new leadership of Datuk Francis, and the new management team, the airline successfully launched three more new international routes by the end of 2023. In 2024, the airline continued growing its international and domestic route and at the same time recording historical firsts that also became a significant industry first for the Indonesian aviation industry. Since April 2023, TransNusa has been making headlines in Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and diving haven, Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided Indonesians with more pricing and route options to China.TransNusa’s aggressive international growth strategy combined with its domestic business operations approach has enabled the airline to be the fastest growing airline in South East Asia.About TransNusaTransNusa Airline, is a Premium Service Carrier. After the take-over, in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022.  In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently has bases in Jakarta, Bali and Manado.The airline currently flies from Jakarta to Yogyakarta, Bali, Kuala Lumpur, Malaysia, Subang, Malaysia and Guangzhou, China. It also flies from Bali to Jakarta and Manado. TransNusa will be launching its scheduled Bali to Perth route on March 20th and its Bali to Guangzhou route on April13th. TransNusa made history when it became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at, +62216310888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd, at +65 86602719 for assistance.TransNusa’s Primary Media Contact:Trina Thomas Rajtrina@myqaseh.org+60124992672 (watsapp) Copyright 2025 ACN Newswire via SeaPRwire.com.

DUBAI, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - 31 Concept (31C), an emerging leader in network intelligence and cybersecurity innovation, today announced it will unveil its first patent-pending technology at ISS Asia 2025 in Singapore. The breakthrough, developed entirely within the company's 31 Concept Research Lab, marks a major milestone for the startup, which is stepping out of stealth mode after just seven months of intense development.31 Concept's Innovation PatentedThe 31 Concept Research Lab serves as the company's innovation engine, uniting world-class experts in deep packet inspection, AI-driven analytics, cybersecurity, and advanced networking. With decades of combined experience from projects spanning telecom, military, and national infrastructure, the lab's team operates at the intersection of applied research and practical deployment, delivering solutions designed to solve real-world challenges at scale."Our patent-pending technology is the direct result of the unique expertise and relentless drive inside our Research Lab," said Misha Hanin, CEO and Co-Founder of 31C. "We built this in record time without compromising on quality or innovation. This is just the first step in a series of breakthroughs we intend to bring to the market."ISS Asia, recognized as one of the most important professional conferences in the world for intelligence, security, and law enforcement technologies, will provide the global stage for the debut. The event draws leaders from government, telecom, and private industry, making it the perfect venue for 31C's first public presentation."The speed at which the 31 Concept Research Lab turned a concept into a patent-pending reality shows the strength of our people and our process," added Boriss Heismann, CTO of 31C. "This is technology designed to address the most pressing needs in network visibility, security, and performance - and to do it in ways the industry has not seen before."The company's presentation at ISS Asia 2025 will highlight the capabilities of the new platform, detail the patent-pending elements, and outline the roadmap for further innovations currently in development.About 31C31 Concept is a technology company focused on next-generation data intelligence platforms for telecom providers, governments, and regulated industries. Its flagship R&D division, the 31 Concept Research Lab, develops breakthrough technologies in network intelligence, cybersecurity, and AI-driven analytics.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 ConceptRelated Images Copyright 2025 ACN Newswire via SeaPRwire.com.

KUALA LUMPUR, Aug 8, 2025 - (ACN Newswire via SeaPRwire.com) - Qube Integrated Malaysia Sdn. Bhd. (Qube), a leading local business events industry player celebrating its 20th anniversary this year, won 10 prestigious awards at the Malaysia Business Events Awards (MBEA) 2025, organised by the Malaysian Association of Convention and Exhibition Organisers and Suppliers (MACEOS) last night.The company, an established name in the MICE (Meetings, Incentives, Conferences and Exhibitions) industry, was honoured at the event held at the Kuala Lumpur Convention Centre with five Excellence Awards and five Merit Awards, out of the 10 categories it was shortlisted for, including:1. Exhibition Management Excellence Award: Qube for Malaysia International Halal Showcase (MIHAS) 20242. Trade Exhibition Excellence Award for events between 10,001–20,000 sqm: BuildXpo Malaysia 20243. Booth Design Excellence Award for booths below 72sqm held in overseas: MyCEB Pavilion at IMEX Frankfurt4. Booth Design Excellence Award for single deck booth 73 sqm & above: Proton Pavilion at KLIMS 20245. Stage Design Excellence Award: Acer APAC Predator League 20256. Trade Exhibition Excellence Merit Award (20,001 sqm and above): MIHAS 20247. Event Excellence (B2B – Corporate) Merit Award: Proton e.MAS 7 Grand Launch8. Booth Design Excellence Merit Award (Double Deck): Malaysia Airlines @ MATTA Fair – March 20249. Merit Award Booth Design Excellence Merit Award (Double Deck): Malaysia Airlines @ MATTA Fair – Sept 202410. Purpose-Built Venue Excellence Merit Award (15,001 sqm and above): Malaysia International Trade and Exhibition Centre (MITEC)Founded in 2005 and headquartered in Kuala Lumpur, Qube marks its 20th anniversary this year with a bold step forward in digital innovation, talent development, and regional collaboration. Reinforcing its long-term commitment to shaping the future of MICE, the company has announced several new initiatives that underline its role as a strategic player in Malaysia’s trade and tourism growth.Over the last two decades, Qube has grown from a boutique design-and-build agency into a powerhouse for creative and executional excellence in exhibitions and events. The company has delivered Malaysia’s pavilions at global showcases, including Expo 2017 Astana and Expo 2020 Dubai, which drew millions of visitors. In 2024, Qube set a significant milestone when the company acquired the tenure to manage the Malaysia International Trade and Exhibition Centre (MITEC), the country’s largest business events venue.In 2024, Qube also acquired SEA Healthcare & Pharma Show (SEACare), a long-running business trade exhibition in the medical and pharma sector. Most recently, Qube designed, built and managed the Malaysia Pavilion at the 2025 Mobile World Congress in Barcelona, and continues to manage MIHAS, the world’s largest halal trade fair and a Guinness World Records title holder.On this achievement, Richard Teo, Executive Chairman of Qube, said: “This recognition means a great deal to us. It reflects the dedication of our team, the trust of our clients, and the strength of the partnerships we have built. These platforms do more than showcase what we can do. They position Malaysian brands globally, create new opportunities for SMEs, and attract long-term business and investment into the country.”“Business events are not just about putting people in the same room. They help drive innovation, stimulate economic activity, support jobs and strengthen supply chains. At the heart of it all, we are focused on creating meaningful impact for our clients, our people and the nation,” he added.Collaboration with the Public SectorQube continues to work closely with public agencies including MATRADE, the Construction Industry Development Board (CIDB), the Malaysia Convention & Exhibition Bureau (MyCEB) and others. These partnerships align with national priorities under the 13th Malaysia Plan and ongoing tourism recovery efforts, particularly in SME development, export growth, talent upskilling and business event-driven tourism.Looking ahead, Qube will play a central role in several major upcoming platforms:MIHAS 2025, in partnership with MATRADESME Venture@ASEAN 2025, with SME Corporation MalaysiaICW & BuildXpo 2025, co-organised with CIDB MalaysiaIn addition, Qube will host its signature event, WE2025: Future in Motion, a flagship initiative for empowering women in business, leadership, and innovation, from 25 to 27 November 2025. Themed Women in Trade. Investment. Leadership., this multi-platform event is organised in collaboration with the Ministry of Women, Family and Community Development and the Department of Women Development.WE2025 features four integrated pillars: a leadership conference, a large-scale trade and investment expo, curated business matching and key side events.Aimed at women entrepreneurs, corporate leaders, SMEs, startups, youth, ecosystem enablers and inclusive industries from across ASEAN and beyond, WE2025: Future in Motion is expected to attract 10,000 visitors, 1,000 delegates, 500 exhibitor booths, and generate RM100 million in trade and investment opportunities.“We have always believed in using our platforms to make a lasting difference. Whether it is through delivering a high-impact trade show, empowering local brands, or raising the bar in venue management, our purpose has remained the same. Our growth is powered by talent, shaped by innovation, and guided by the values of inclusivity and excellence,” added Teo.Contacts for Media Enquiries:  MNAIR PR Consultancy Sdn. Bhd.Sashikala NairDirector, Public Relations+6012 566 9095sashi@mnairpr.comShuman VasuAssociate Director, Public Relations+6017 354 6461shumanv@mnairpr.comQube Integrated Malaysia Sdn. Bhd. (Qube)Yasmin BathamanathanManager, PR & Communications+6012 358 9063yasmin@qube.com.my Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - 5 August, The well-known dual-listed beauty and skincare group in Asia, Natural Beauty Bio-Technology Limited ("Natural Beauty"), together with its subsidiaries (the "Group"; Hong Kong stock code: 00157), today announced its interim results for the six months ended 30 June 2025 (the "Review Period"). The Group's turnover and profit for the Review Period soared by nearly 70% to over HK$260 million and 136% to HK$11 million, respectively. A good number of its core indicators for the period also reached record highs, evidencing the strong development resilience and growth potential of the Group in the beauty and skincare sector.Mainland China, which is the core market of the Group, recorded turnover HK$220 million in the first half of 2025, up 101% year-on-year, and has thus become the main driving force of the Group’s overall performance growth. In terms of channels, the franchise model performed particularly well, contributing turnover of HK$200 million, a 115% increase year-on-year. In the Review Period, 237 new franchise stores were added, a leap of 88%. The rapidly expanding store network has given the segment solid support for turnover growth. Turnover from self-owned channels (including counters) climbed by 112% to HK$13 million, reflecting the success of its refined retail operations. In addition, the turnover of the health supplements segment also grew by 110%, to HK$28 million, a testament to the success of the Group’s “Holistic Health” strategy.Dr. Lei Chien, Chairman and Executive Director of Natural Beauty, said, "The Group's ‘AI Technology, Beauty Industry, Holistic Health’ strategy has brought remarkable results and enabled us to transform our brand. In AI technology development, our strategic partnership with Spain's INDIBA has enabled the integration of their cutting-edge devices with our proprietary formulations, resulting in the co-created White Moonlight product series. By combining advanced international technology with our proprietary skincare solutions, we've transformed the series into a market bestseller - clear validation of this collaborative model's effectiveness.Mr. CHENG Chi-Chung, who has just completed his first year as the Group CEO, has led the team in strategically expanding the beauty ecosystem by introducing an agent-based store expansion and partnership model, driving rapid growth in the franchising channel. He said:” We have established a comprehensive 'Standardized Operations System + End-to-End Support Framework', enabling franchisees to replicate successful models efficiently. This system has facilitated the successful launch of 237 new stores in the first half of this year, all achieving strong business growth.Beyond the dual growth in cosmetics and AI devices, our "Total Wellness" strategy for health supplements delivered outstanding results - generating HK$28 million in revenue with nearly 110% year-on-year growth. The success stems from two key factors: firstly, the products, which closely align with consumers health demand of ‘internal and external nutrition’, are made with premium ingredients sourced globally and technically supported by cross-strait R&D centers apt in delivering high-quality nutritional solutions, and secondly, integrating with ‘Holistic Health’ scenarios, health supplements are promoted alongside skincare services to create closed-loop consumption. That confirms the strong market recognition we enjoy for our comprehensive ‘skincare + health management’ solutions.”Looking ahead, benefiting from consumption rebounding and industry upgrade, the Group will, with its “AI Technology, Beauty Industry, Holistic Health" strategy at the core, push forward in two key directions: continue to integrate industrial chain resources to speed up digital transformation across channels, and use big data to accurately capture demand and build a “demand—R&D—channels” closed-loop system to reinforce the market leadership.Photo caption:Nature Beauty OutletAbout Natural Beauty Bio-Technology Limited (Hong Kong stock code:00157)A China’s leading listed beauty and skincare brand established in 1972, has championed its core philosophy of "Natural Beauty Is True Beauty" for 54 years. Driven by its "AI Technology, Beauty Industry, Holistic Health" integrated strategy, the brand operates a global network of over 2,000 outlets. As a Chinese-origin transnational biotech pioneer, Natural Beauty continues to propel innovation in the cosmetics and skincare sector.Media enquiriesStrategic Financial Relations LimitedMandy GoTel: +852 2864 4812Email: mandy.go@sprg.com.hk Maggie ZhangTel: +852 2114 4903Email: maggie.zhang@sprg.com.hk Website:http://www.sprg.com.hk  Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 8, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R). NEFECON(R) is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression, irrespective of proteinuria levels.With this label update, the previous requirement in accelerated approval stage to submit full confirmatory trial analysis to demonstrate clinical benefit has been formally removed. Additionally, data demonstrating NEFECON(R)’s efficacy in delaying kidney function decline has been included in the approved product label. IgAN is highly prevalent among Asian populations, with a 56% higher risk of progression to end-stage renal disease compared to other groups and often progresses more rapidly.Taiwan region became the last region across all Everest’s territories to grant full approval for NEFECON(R), together with Mainland China, Singapore, Macao SAR, Hong Kong SAR and South Korea. This further demonstrates NEFECON(R)’s foundational first-line cornerstone treatment for IgAN patients."NEFECON(R) has received full approval in Taiwan, further validating its outstanding clinical value and offering physicians a more solid clinical foundation for treatment decisions.” Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines, said. “As the first and only fully approved etiological treatment for IgAN, NEFECON(R) has now achieved full approval across Asia. This milestone will benefit a broader patient population by enabling more individuals with IgAN to access this etiological treatment earlier, helping to slow disease progression and improve quality of life. We will continue to expand the accessibility and affordability of NEFECON(R) across Asia, aiming to benefit more IgAN patients and improve their quality of life."The approval is based on the global Phase 3 NefIgArd clinical trial, which showed that compared to placebo, it not only brought about a durable reduction in proteinuria and reduced the frequency of microscopic hematuria but also demonstrated clinically relevant and statistically significant treatment benefits in estimated glomerular filtration rate (eGFR), reducing the decline in kidney function by 50% over a period of 2 years, comprising 9 months of treatment and 15 months of observation, and potentially delaying the progression to dialysis or kidney transplantation by 12.8 years.Additionally, the complete 2-year data of the NefIgArd study further analyzed the potential differences in the response to NEFECON(R) treatment between Asians (n=83) and Caucasians (n=275). The results showed that compared to placebo, treatment with NEFECON(R) for 9 months in both Asians and Caucasians can significantly delay the decline of eGFR, protect kidney function, and bring about a sustained reduction in proteinuria and reduce the risk of microscopic hematuria.NEFECON(R) has been recommended by several authoritative treatment guidelines, including the “KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (Public Review Draft)”, and the "Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)". NEFECON(R) was included in China’s National Reimbursement Drug List (NRDL) in November 2024, and the supplemental application for the production expansion of NEFECON(R) has been officially approved by NMPA in August 2025.NEFECON(R) is currently the world’s first IgAN treatment to have received full approval from the National Medical Products Administration (NMPA) in China, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency（MHRA）in the United Kingdom , as well as in other Asian territories where Everest Medicines holds the rights, including Hong Kong SAR, Macao SAR, Taiwan region (China), Singapore, and South Korea. Copyright 2025 ACN Newswire via SeaPRwire.com.

RIYADH, KSA, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - Saudi Electricity Company (SEC) continued to deliver robust financial and operational performance in the second quarter and first half of 2025.Revenue for Q2 grew by 24% to reach SAR 27.7 billion, while gross profit rose by 42% to SAR 7.4 billion. Operating profit increased by 21% to SAR 6.8 billion, and net profit reached SAR 5.3 billion-marking a 22% year-on-year increase.For the first half of 2025, SEC reported a revenue growth of 23%, totalling SAR 47.2 billion. Gross profit rose by 40% to SAR 10.2 billion, operating profit increased by 20% to SAR 9.1 billion, and net profit grew by 19% to SAR 6.3 billion compared to the same period in 2024.This strong financial performance was primarily driven by higher allowed revenue due to the growth of the regulated asset base of the electricity network and increased electricity production revenues in response to rising energy demand. These gains were partially offset by higher operating and maintenance expenses due to network expansion, asset growth, and increased loads, as well as a rise in provisions for accounts receivable and a decrease in other income.SEC noted that the expansion of its regulated asset base reflects the continued growth in its transmission and distribution networks to meet increasing electricity demand, support renewable energy integration, and advance energy storage projects. The company is also maintaining strategic investments in digital transformation and operational excellence initiatives.Commenting on the results, Engineer Khalid bin Salim Al-Ghamdi, Acting CEO of SEC, stated:"Our positive performance in the first half of 2025 reflects the company's continued growth across its business portfolio and asset base. It aligns with our strategy to provide reliable and secure electricity across the Kingdom, improve service quality for our customers, and advance sustainability and operational excellence.We are committed to further strengthening our position and leveraging the significant opportunities emerging from the energy transition in Saudi Arabia, in line with the ambitions of Vision 2030-enabled by the dedication of our talented national workforce and our unwavering commitment to serving the nation."As of the end of H1 2025, the renewable energy capacity connected to the grid exceeded 9.2 GW, and the company successfully commissioned 8.0 GWh of battery energy storage systems across four sites: Bisha, Jazan, Khamis Mushait, and Najran.SEC is currently developing an additional 14 GWh of storage capacity, expected to be operational and grid-connected next year, further strengthening grid reliability and renewable energy integration.Reaffirming its commitment to embedding sustainability throughout its operations and enhancing its ESG practices, SEC achieved a significant leap in its Environmental, Social, and Governance (ESG) rating from S&P Global, earning 65 out of 100 in 2025. This marks a 30% increase over2024 and an 85% improvement over 2023.This accomplishment places SEC at the top of all companies in Saudi Arabia and as the regional leader in the energy sector across the Middle East and North Africa, surpassing the global utilities sector average by 66%, reinforcing its global leadership in sustainability performance.Electricity demand continued to rise in H1 2025, with peak load growing by 3% to 75.1 GW, and total electricity consumption increasing by 10% to reach 160.5 terawatt-hours.SEC successfully met record-breaking peak loads in Makkah, Madinah, and the Holy Sites during the 1446H Hajj season without a single service interruption-thanks to the company's full mobilization of resources to serve pilgrims and ensure their comfort.The company also made strong progress in service expansion and infrastructure development. SEC connected around 110,000 new customers, bringing the total customer base to 11.4 million.The length of the distribution network grew by 6% to exceed 827,000 circuit kilometers, while transmission and fiber optic networks grew by 6% and 9%, respectively, reaching 103.8 thousand and 101 thousand circuit kilometers.As part of its efforts to enhance service reliability and customer experience, SEC continued digital infrastructure upgrades and automated distribution substations, connecting them to control centers via fiber optic networks.The automation rate of distribution substations reached 38.4%, and customer satisfaction rose to 85.8%, underscoring improvements in service quality and communication effectiveness.Contact InformationSaudi Electricity Company (SEC) Saudi Electricity Company (SEC)Media Relations Departmentalkahrabacare@se.com.saUnified Call Center: 920000222SOURCE: Saudi Electricity Company (SEC) Copyright 2025 ACN Newswire via SeaPRwire.com.